Asia Pacific Prenatal And Newborn Genetic Testing Market Scope And Analysis

  • Report Code : TIPRE00006470
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 281
Buy Now

Asia Pacific Prenatal & Newborn Genetic Testing Market Analysis and Scope (2019 to 2027)

Buy Now

Asia Pacific Prenatal & Newborn Genetic Testing Market Report Asia Pacific Prenatal & Newborn Genetic Testing Market Size and Share Asia Pacific Prenatal & Newborn Genetic Testing Market Scope and Analysis

Asia Pacific Prenatal & Newborn Genetic Testing Market Report Scope

Report Attribute Details
Market size in 2018 US$ 630.914 Million
Market Size by 2027 US$ 1,679.956 Million
Global CAGR (2019 - 2027) 11.6%
Historical Data 2016-2017
Forecast period 2019-2027
Segments Covered By Product
  • Diagnostic
  • Screening
By Disease Indication
  • Cystic Fibrosis
  • Sickle Cell Anemia
  • Down Syndrome
  • Phenylketonuria
  • Recurrent Pregnancy Loss
  • Antiphospholipid Syndrome
  • Other Diseases
By Technology
  • Spectrophotometer
  • Polymerase Chain Reaction
  • Fluorescence In-situ Hybridization
  • Array Comparative Genomic Hybridization
By End User
  • Hospitals & Clinics
  • Diagnostic Centers
  • Other End User
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • LifeCell
  • Quest Diagnostics Incorporated
  • Medgenome
  • Eurofins Scientific
  • Metropolis India
  • SRL Diagnostics
  • Sandor Lifesciences Pvt Ltd
  • PerkinElmer Inc
  • Natera Inc